Clinical and biochemical signs of polycystic ovary syndrome in young women born preterm

OBJECTIVE: It has been suggested that adverse early life exposures increase the risk of developing polycystic ovary syndrome (PCOS) in later life. We hypothesized that women born preterm would have more biochemical and clinical signs of PCOS than women born at term. DESIGN: The ESTER Preterm Birth S...

Full description

Bibliographic Details
Published in:European Journal of Endocrinology
Main Authors: Paalanne, Marika, Vääräsmäki, Marja, Mustaniemi, Sanna, Tikanmäki, Marjaana, Wehkalampi, Karoliina, Matinolli, Hanna-Maria, Eriksson, Johan, Järvelin, Marjo-Riitta, Morin-Papunen, Laure, Kajantie, Eero
Format: Text
Language:English
Published: Bioscientifica Ltd 2021
Subjects:
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284903/
http://www.ncbi.nlm.nih.gov/pubmed/34081616
https://doi.org/10.1530/EJE-20-1462
id ftpubmed:oai:pubmedcentral.nih.gov:8284903
record_format openpolar
spelling ftpubmed:oai:pubmedcentral.nih.gov:8284903 2023-05-15T17:42:20+02:00 Clinical and biochemical signs of polycystic ovary syndrome in young women born preterm Paalanne, Marika Vääräsmäki, Marja Mustaniemi, Sanna Tikanmäki, Marjaana Wehkalampi, Karoliina Matinolli, Hanna-Maria Eriksson, Johan Järvelin, Marjo-Riitta Morin-Papunen, Laure Kajantie, Eero 2021-06-03 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284903/ http://www.ncbi.nlm.nih.gov/pubmed/34081616 https://doi.org/10.1530/EJE-20-1462 en eng Bioscientifica Ltd http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284903/ http://www.ncbi.nlm.nih.gov/pubmed/34081616 http://dx.doi.org/10.1530/EJE-20-1462 © The authors https://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) . CC-BY Eur J Endocrinol Clinical Study Text 2021 ftpubmed https://doi.org/10.1530/EJE-20-1462 2021-07-25T00:36:44Z OBJECTIVE: It has been suggested that adverse early life exposures increase the risk of developing polycystic ovary syndrome (PCOS) in later life. We hypothesized that women born preterm would have more biochemical and clinical signs of PCOS than women born at term. DESIGN: The ESTER Preterm Birth Study participants were born in Northern Finland and identified from the Northern Finland Birth Cohort and the Finnish Medical Birth Register. Altogether, 74 women born very or moderately preterm (<34 gestational weeks, VMPT), 127 born late preterm (at 34–36 weeks, LPT), and 184 born full term (≥37 weeks, controls) were included in the analysis (mean age: 23.2 years). METHODS: We measured serum total testosterone and sex hormone-binding globulin (SHBG) and calculated the free androgen index (FAI). PCOS according to the clinical and biochemical signs was defined either as hirsutism and oligoamenorrhea (via questionnaire) or as oligoamenorrhea and elevated testosterone levels (>2.4 nmol/L). RESULTS: Women born VMPT/LPT exhibited 33.0% (8.7, 62.8)/16.4% (−2.0, 38.1) higher testosterone, 28.5% (5.3, 45.9)/24.1% (5.6, 38.9) lower SHBG levels, and 64.6% (19.4, 127.1)/42.5% (11.1, 82.9) higher FAI than controls after adjusting for age and recruitment cohort, maternal BMI, smoking, and pregnancy disorders, parental education, history of hypertension, diabetes, myocardial infarction or stroke, and subject’s birth weight s.d. Odds ratios for having PCOS were 1.67 (0.44, 6.23)/3.11 (1.26, 7.70). CONCLUSIONS: Women born preterm have a more hyperandrogenic hormonal profile, and those born LPT are approximately three times more likely at risk to have PCOS compared to women born at term. Text Northern Finland PubMed Central (PMC) European Journal of Endocrinology 185 2 279 288
institution Open Polar
collection PubMed Central (PMC)
op_collection_id ftpubmed
language English
topic Clinical Study
spellingShingle Clinical Study
Paalanne, Marika
Vääräsmäki, Marja
Mustaniemi, Sanna
Tikanmäki, Marjaana
Wehkalampi, Karoliina
Matinolli, Hanna-Maria
Eriksson, Johan
Järvelin, Marjo-Riitta
Morin-Papunen, Laure
Kajantie, Eero
Clinical and biochemical signs of polycystic ovary syndrome in young women born preterm
topic_facet Clinical Study
description OBJECTIVE: It has been suggested that adverse early life exposures increase the risk of developing polycystic ovary syndrome (PCOS) in later life. We hypothesized that women born preterm would have more biochemical and clinical signs of PCOS than women born at term. DESIGN: The ESTER Preterm Birth Study participants were born in Northern Finland and identified from the Northern Finland Birth Cohort and the Finnish Medical Birth Register. Altogether, 74 women born very or moderately preterm (<34 gestational weeks, VMPT), 127 born late preterm (at 34–36 weeks, LPT), and 184 born full term (≥37 weeks, controls) were included in the analysis (mean age: 23.2 years). METHODS: We measured serum total testosterone and sex hormone-binding globulin (SHBG) and calculated the free androgen index (FAI). PCOS according to the clinical and biochemical signs was defined either as hirsutism and oligoamenorrhea (via questionnaire) or as oligoamenorrhea and elevated testosterone levels (>2.4 nmol/L). RESULTS: Women born VMPT/LPT exhibited 33.0% (8.7, 62.8)/16.4% (−2.0, 38.1) higher testosterone, 28.5% (5.3, 45.9)/24.1% (5.6, 38.9) lower SHBG levels, and 64.6% (19.4, 127.1)/42.5% (11.1, 82.9) higher FAI than controls after adjusting for age and recruitment cohort, maternal BMI, smoking, and pregnancy disorders, parental education, history of hypertension, diabetes, myocardial infarction or stroke, and subject’s birth weight s.d. Odds ratios for having PCOS were 1.67 (0.44, 6.23)/3.11 (1.26, 7.70). CONCLUSIONS: Women born preterm have a more hyperandrogenic hormonal profile, and those born LPT are approximately three times more likely at risk to have PCOS compared to women born at term.
format Text
author Paalanne, Marika
Vääräsmäki, Marja
Mustaniemi, Sanna
Tikanmäki, Marjaana
Wehkalampi, Karoliina
Matinolli, Hanna-Maria
Eriksson, Johan
Järvelin, Marjo-Riitta
Morin-Papunen, Laure
Kajantie, Eero
author_facet Paalanne, Marika
Vääräsmäki, Marja
Mustaniemi, Sanna
Tikanmäki, Marjaana
Wehkalampi, Karoliina
Matinolli, Hanna-Maria
Eriksson, Johan
Järvelin, Marjo-Riitta
Morin-Papunen, Laure
Kajantie, Eero
author_sort Paalanne, Marika
title Clinical and biochemical signs of polycystic ovary syndrome in young women born preterm
title_short Clinical and biochemical signs of polycystic ovary syndrome in young women born preterm
title_full Clinical and biochemical signs of polycystic ovary syndrome in young women born preterm
title_fullStr Clinical and biochemical signs of polycystic ovary syndrome in young women born preterm
title_full_unstemmed Clinical and biochemical signs of polycystic ovary syndrome in young women born preterm
title_sort clinical and biochemical signs of polycystic ovary syndrome in young women born preterm
publisher Bioscientifica Ltd
publishDate 2021
url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284903/
http://www.ncbi.nlm.nih.gov/pubmed/34081616
https://doi.org/10.1530/EJE-20-1462
genre Northern Finland
genre_facet Northern Finland
op_source Eur J Endocrinol
op_relation http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284903/
http://www.ncbi.nlm.nih.gov/pubmed/34081616
http://dx.doi.org/10.1530/EJE-20-1462
op_rights © The authors
https://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) .
op_rightsnorm CC-BY
op_doi https://doi.org/10.1530/EJE-20-1462
container_title European Journal of Endocrinology
container_volume 185
container_issue 2
container_start_page 279
op_container_end_page 288
_version_ 1766144185808715776